Amarin Corp Plcuk (AMRN) Non-Current Debt (2010 - 2019)

Amarin Corp Plcuk (AMRN) posted quarterly Non-Current Debt of $8.9 million for Q3 2019, down 69.55% YoY from $29.2 million in Q3 2018, and down 61.74% sequentially from $23.2 million in Q2 2019.

Amarin Corp Plcuk (AMRN) Non-Current Debt (2010 - 2019) Analysis & Trends

Amarin Corp Plcuk has disclosed Non-Current Debt across 10 years of filings, most recently posting $8.9 million for Q3 2019.

  • In Q3 2019, Non-Current Debt fell 69.55% year-over-year to $8.9 million; the TTM figure through Sep 2019 stood at $8.9 million (down 69.55% YoY), while the FY2018 annual figure was $46.1 million, up 59.04% from the prior year.
  • Non-Current Debt slipped to $8.9 million in Q3 2019, from $23.2 million in the prior quarter.
  • Over the last five years, Non-Current Debt for AMRN reached as high as $136.7 million in Q4 2015 and fell as low as $8.9 million in Q3 2019.
  • The 5-year median for Non-Current Debt is $62.7 million (2017), against an average of $64.7 million.
  • Annual changes were most pronounced in 2018 — Non-Current Debt jumped 59.04% — and 2019, when it sank 69.55%.
  • A 5-year view of Non-Current Debt shows it stood at $136.7 million in 2015, then plunged by 37.72% to $85.2 million in 2016, then slumped by 65.95% to $29.0 million in 2017, then jumped by 59.04% to $46.1 million in 2018, then slumped by 80.75% to $8.9 million in 2019.
  • According to Business Quant data, Non-Current Debt over the past three periods registered $8.9 million, $23.2 million, and $35.3 million for Q3 2019, Q2 2019, and Q1 2019 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 39.37 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 37.53 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 64.53 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -24.45 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 46.67 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 51.89 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 20.86 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 60.57 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2019 8.88 Mn
Jun 30, 2019 23.20 Mn
Mar 31, 2019 35.34 Mn
Dec 31, 2018 46.11 Mn
Sep 30, 2018 29.16 Mn
Jun 30, 2018 29.10 Mn
Mar 31, 2018 29.05 Mn
Dec 31, 2017 28.99 Mn
Sep 30, 2017 28.94 Mn
Jun 30, 2017 79.28 Mn
Mar 31, 2017 82.41 Mn
Dec 31, 2016 85.16 Mn
Jun 30, 2016 125.64 Mn
Mar 31, 2016 92.02 Mn
Dec 31, 2015 136.73 Mn
Sep 30, 2015 91.01 Mn
Jun 30, 2015 90.52 Mn
Mar 31, 2015 123.19 Mn
Dec 31, 2014 121.85 Mn
Sep 30, 2014 120.49 Mn